Replacement treatment with Testosterone has been a controversial issue along the last 5 years. Despite the average good response to treatment many scientist disagree with the proposal of giving Testosterone on the bases of clinical evidence of Low Sexual Desire without dosage of Testosterone blood level. Our objectives were to treat an adult male population (n=200) which presented Low Sexual Desire with intramuscular (Duratestone, Lilly) and transdermal fixed doses of Testosterone (Androlone gel, Beta).
We compared results with a population (n= 100) with the same diagnosis and refused treatment. Statistical studies are still being performed. Patients included: Adam test more than four points. Patients excluded: prostate cancer or PSA more than 4 mgrs/ml. All patients have a PSA dosage one month after treatment. A clinical evaluation was done after treatment. Clearly significant beneficial effects were obtained after Testosterone treatment. Sexual Desire and sexual fantasies improved. Many patients improved some degree of Erectile Dysfunction. More investigation is requiered on this interesting point describing the role of Testosterone on Sexual Desire and Erectile Dysfunction.
Conflict of Interest: None disclosed
Financial Support/Funding: None disclosed
Recorded at 19th WAS World Congress for Sexual Health - Sexual Health & Rights: A Global Challenge Göteborg (Sweden) - June 21 – 25, 2009
more about this speaker
